Breaking News, Collaborations & Alliances

PharmOptima & Ophthy-DS Announce Collaboration

To offer pharmaceutical companies a single reliable source for ocular drug discovery, development, safety, and pharmacokinetics

PharmOptima, a member of Genesis Drug Discovery & Development (GD3), and Ophthy-DS have announced a collaborative operating agreement.  Together, PharmOptima and Ophthy-DS will leverage their complimentary expertise to offer pharmaceutical companies a single reliable source for ocular drug discovery, development, safety, and pharmacokinetics. With this agreement, clients will gain increased access to an integrated portfolio of drug discovery services—from target validation and assay d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters